Frederick G. Barker

3.0k total citations
45 papers, 1.1k citations indexed

About

Frederick G. Barker is a scholar working on Epidemiology, Neurology and Genetics. According to data from OpenAlex, Frederick G. Barker has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 19 papers in Neurology and 14 papers in Genetics. Recurrent topics in Frederick G. Barker's work include Meningioma and schwannoma management (18 papers), Glioma Diagnosis and Treatment (14 papers) and Brain Metastases and Treatment (9 papers). Frederick G. Barker is often cited by papers focused on Meningioma and schwannoma management (18 papers), Glioma Diagnosis and Treatment (14 papers) and Brain Metastases and Treatment (9 papers). Frederick G. Barker collaborates with scholars based in United States, Canada and Switzerland. Frederick G. Barker's co-authors include John W. Henson, Mitchel S. Berger, Tony E. Godfrey, Michael D. Prados, Janice Nigro, Susan M. Chang, Martha L. Simmons, Kenneth Aldape, Kathleen R. Lamborn and Mark A. Israel and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Radiology.

In The Last Decade

Frederick G. Barker

39 papers receiving 1.0k citations

Peers

Frederick G. Barker
E. C. Quant United States
Robert Cavaliere United States
L. Feuvret France
Robert V. Jones United States
Christopher McPherson United States
M. Polivka France
Frederick G. Barker
Citations per year, relative to Frederick G. Barker Frederick G. Barker (= 1×) peers Paolo Nozza

Countries citing papers authored by Frederick G. Barker

Since Specialization
Citations

This map shows the geographic impact of Frederick G. Barker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick G. Barker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick G. Barker more than expected).

Fields of papers citing papers by Frederick G. Barker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick G. Barker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick G. Barker. The network helps show where Frederick G. Barker may publish in the future.

Co-authorship network of co-authors of Frederick G. Barker

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick G. Barker. A scholar is included among the top collaborators of Frederick G. Barker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick G. Barker. Frederick G. Barker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Grace, Andrzej Niemierko, Nayan Lamba, et al.. (2025). Toxicities Associated with Adjuvant Radiation Therapy in Atypical Meningioma. Advances in Radiation Oncology. 10(3). 101726–101726.
2.
Mehta, Neel H., Emre Kiziltug, Phan Q. Duy, et al.. (2024). Utility of cortical tissue analysis in normal pressure hydrocephalus. Cerebral Cortex. 34(2). 6 indexed citations
3.
Hua, Lingyang, Shingo Fujio, Sylvia Herold, et al.. (2024). Genetic characterization and mutational profiling of foramen magnum meningiomas: a multi-institutional study. Journal of neurosurgery. 141(1). 72–78. 3 indexed citations
4.
Brastianos, Priscilla K., Susan M. Geyer, Elizabeth R. Gerstner, et al.. (2024). Alliance A071401: Phase II trial of abemaciclib in patients with grade 2/3 meningiomas harboring somatic NF2 or CDK pathway alterations.. Journal of Clinical Oncology. 42(16_suppl). 2001–2001. 2 indexed citations
5.
Plotkin, Scott R., Frederick G. Barker, D. Bradley Welling, et al.. (2023). Proton Radiotherapy for Vestibular Schwannomas in Patients with NF2-Related Schwannomatosis: A Case Series. Current Oncology. 30(3). 3473–3483.
6.
Iliopoulos, Othon, Otto Rapalino, Frederick G. Barker, et al.. (2023). Belzutifan treatment of Von Hippel-Lindau (VHL) related central nervous system (CNS) hemangioblastomas (HBs): A single institution experience.. Journal of Clinical Oncology. 41(16_suppl). 2078–2078. 3 indexed citations
7.
Plotkin, Scott R., Priya Kumthekar, Patrick Y. Wen, et al.. (2021). Multi-center, single arm phase II study of the dual mTORC1/mTORC2 inhibitor vistusertib for patients with recurrent or progressive grade II-III meningiomas.. Journal of Clinical Oncology. 39(15_suppl). 2024–2024. 5 indexed citations
8.
Brastianos, Priscilla K., Erin Twohy, Susan Geyer, et al.. (2021). Alliance A071601: Phase II trial of BRAF/MEK inhibition in newly diagnosed papillary craniopharyngiomas.. Journal of Clinical Oncology. 39(15_suppl). 2000–2000. 17 indexed citations
9.
Brastianos, Priscilla K., Erin Twohy, Elizabeth R. Gerstner, et al.. (2020). Alliance A071401: Phase II trial of FAK inhibition in meningiomas with somatic NF2 mutations.. Journal of Clinical Oncology. 38(15_suppl). 2502–2502. 22 indexed citations
10.
Palmer, Joshua D., Brett Klamer, Karla V. Ballman, et al.. (2020). Effect of Stereotactic Radiosurgery Compared to Whole-brain Radiotherapy for Limited Brain Metastasis on Long Term Cognition and Quality of Life: A Pooled Analysis of NCCTG N107C/CEC.3 and N0574 (Alliance) Randomized Clinical Trials. International Journal of Radiation Oncology*Biology*Physics. 108(3). S175–S176. 2 indexed citations
11.
Hwang, William L., Ariel E. Marciscano, Anat Stemmer‐Rachamimov, et al.. (2015). Correlation of Imaging Characteristics With Histopathological WHO Grade in Meningiomas. International Journal of Radiation Oncology*Biology*Physics. 93(3). E86–E86.
12.
Brown, Paul D., Anthony L. Asher, Karla V. Ballman, et al.. (2015). NCCTG N0574 (Alliance): A phase III randomized trial of whole brain radiation therapy (WBRT) in addition to radiosurgery (SRS) in patients with 1 to 3 brain metastases.. Journal of Clinical Oncology. 33(18_suppl). LBA4–LBA4. 103 indexed citations
13.
Zlotnick, David M., Steven N. Kalkanis, Kevin Kien Hoa Chung, et al.. (2010). FACT-MNG: tumor site specific web-based outcome instrument for meningioma patients. Journal of Neuro-Oncology. 99(3). 423–431. 14 indexed citations
14.
Ulmer, S., et al.. (2006). Clinical and radiographic features of peritumoral infarction following resection of glioblastoma. Neurology. 67(9). 1668–1670. 101 indexed citations
15.
Cady, Blake, Frederick G. Barker, Alexandra Easson, et al.. (2005). Part 3: Surgical palliation of advanced illness: What’s new, what’s helpful. Journal of the American College of Surgeons. 200(3). 457–466. 5 indexed citations
16.
Mavrakis, Anastasios, Elkan F. Halpern, Frederick G. Barker, R. Gilberto González, & John W. Henson. (2005). Diagnostic evaluation of patients with a brain mass as the presenting manifestation of cancer. Neurology. 65(6). 908–911. 33 indexed citations
17.
Rabinov, James D., Patricia Lani Lee, Frederick G. Barker, et al.. (2002). In Vivo 3-T MR Spectroscopy in the Distinction of Recurrent Glioma versus Radiation Effects: Initial Experience. Radiology. 225(3). 871–879. 109 indexed citations
18.
Chapman, Paul H. & Frederick G. Barker. (1998). Microvascular Decompression for Pediatric Onset Trigeminal Neuralgia. Neurosurgery. 43(4). 807–807. 2 indexed citations
19.
Barker, Frederick G., Peter J. Jannetta, Ramesh Babu, et al.. (1996). Long-term outcome after operation for trigeminal neuralgia in patients with posterior fossa tumors. Journal of neurosurgery. 84(5). 818–825. 97 indexed citations
20.
Barker, Frederick G., et al.. (1994). Transethmoidal transsphenoidal approach for embolization of a carotid-cavernous fistula. Journal of neurosurgery. 81(6). 921–923. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026